Reference
- Mamalis N, Anderson CW, Kreisler KR, Lundergan MK, Olson RJ. Changing trends in the indications for pen-etrating keratoplasty. Arch Ophthalmol. 1992;110:1409–1411.
- Kao WW-Y, Vergnes J-P, Ebert J, Sundar-Raj CV, Brown SI. Increased gelatinase and collagenase activities in kera-toconus. Biochem Biophys Res Commun. 1982;107:929–936.
- Rehany U, Lahav M, Shoshan S. Collagenolytic activ-ity in keratoconus. Ann Ophthalmol. 1982;14:751–754.
- Ihalainen A, Salo T, Forsius H, Peltonen L. Increase in type I and type IV collagenolytic activity in primary cultures of keratoconus corneas. Eur J Clin Invest. 1986;16:78–84.
- Kenny MC, Chwa M, Opbroek AJ, Brown DJ. Increased gelatinolytic activity in keratoconus keratocytes. Cornea. 1994;13:114–124.
- Smith VA, Hoh HB, Littleton M, Easty DL. Over-ex-pression of a gelatinase A activity in keratoconus. Eye. 1995;9:429–433.
- Fini ME, Yue BY, Sugar J. Collagenolytic/gelatinolyticmetalloproteinases in normal and keratoconus corneas. Curr Eye Res. 1992;11:849–862.
- Zhou L, Sawaguchi S, Twining SS, Sugar J, Feder RS, Yue, BY. Expression of degradative enzymes and pro-tease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998;39:1117–1124.
- Brown D, Chwa MM, Opbroek A, Kenny MC. Kerato-conus corneas: increased gelatinase activity appears af-ter modification of inhibitors. Curr Eye Res. 1993; 12:571–581.
- Brown D, Chwa M, Escobar M, Kenny MC. Charac-terisation of the major matrix degrading metalloproteinase of human corneal stroma. Evidence for an enzyme/in- hibitor complex. Exp Eye Res. 1991;52:5–16.
- Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase ex-pressed on the surface of invasive tumour cells. Nature. 1994;370:61–65.
- Stronglin AY, Collier Y, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. J Biol Chem. 1995;270: 5331–5338.
- Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y. Membrane-type matrix metallo-proteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 1996;56:2707–2710.
- Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests in-terstitial collagens and other extracellular matrix mac-romolecules. J Biol Chem. 1997;272:2446–2451.
- D'Ortho M-P, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. Membrane-type matrix metalloproteinases 1 and 2 ex-hibit broad spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem. 1997;250:751–757.
- Smine A, Plantner JJ. Membrane type-1 matrix metallo-proteinase in human ocular tissues. Curr Eye Res. 1997;16:925–929.
- Talvensaari A, Apaja-Sarkkinen M, Hoyhtya M, Wester-lund A, Puistola U, Turpeenniemi T. Matrix metallo-proteinase 2 immunoreactive protein appears early in cervical epithelial differentiation. Gynecologic Oncology. 1999;72:306–311.
- Overall CM and Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. In-duction and endogenous activation of collegenase, 72-kDa gelatinase, and Pump-1 is accompanied by the sup-pression of the tissue inhibitor of matrix metalloprotei-nases. J Biol Chem. 1990;265: 21141–21151.